| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/JAC/45.3.321 |
| P698 | PubMed publication ID | 10702551 |
| P2093 | author name string | Colino CI | |
| Sánchez-Navarro A | |||
| Sánchez-Recio MM | |||
| P2860 | cites work | Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. | Q39651339 |
| The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents | Q40517235 | ||
| Pharmacokinetics and pharmacodynamics of newer fluoroquinolones | Q41254190 | ||
| Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa | Q43792942 | ||
| Comparison of ciprofloxacin with ampicillin in acute infectious exacerbations of chronic bronchitis. A double-blind crossover study | Q44303171 | ||
| Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration | Q44483617 | ||
| Use of ciprofloxacin in the treatment of Pseudomonas aeruginosa infections | Q44571334 | ||
| Safety and efficacy of intravenous ciprofloxacin in the treatment of selected infections | Q44587382 | ||
| AUIC--a general target for the optimization of dosing regimens of antibiotics? | Q52298024 | ||
| Statistical moments in pharmacokinetics. | Q52783431 | ||
| A randomised, multinational study with sequential therapy comparing ciprofloxacin twice daily and ofloxacin once daily. | Q54005763 | ||
| The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro | Q24670241 | ||
| Absolute oral bioavailability of ciprofloxacin | Q24685241 | ||
| Basis of anti-infective therapy: pharmacokinetic-pharmacodynamic criteria and methodology for dual dosage individualisation | Q33770248 | ||
| Ciprofloxacin therapy for methicillin-resistant Staphylococcus aureus infections or colonizations | Q35244236 | ||
| Oral ciprofloxacin treatment of Pseudomonas aeruginosa osteomyelitis | Q35253998 | ||
| Treatment of bone, joint, and soft-tissue infections with oral ciprofloxacin | Q35536186 | ||
| Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers | Q35640637 | ||
| The Alexander Project: using in-vitro susceptibility data for choosing empirical therapy in LRTI. | Q36825653 | ||
| Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use. | Q39534055 | ||
| Role of pharmacokinetics in the outcome of infections | Q39639407 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacokinetics | Q323936 |
| pharmacodynamics | Q725307 | ||
| P1104 | number of pages | 8 | |
| P304 | page(s) | 321-328 | |
| P577 | publication date | 2000-03-01 | |
| P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
| P1476 | title | A retrospective analysis of pharmacokinetic/pharmacodynamic indices as indicators of the clinical efficacy of ciprofloxacin. | |
| P478 | volume | 45 |
| Q34207249 | A retrospective analysis of pharmacokinetic-pharmacodynamic parameters as indicators of the clinical efficacy of ceftizoxime |
| Q33982009 | An evaluation of ciprofloxacin pharmacokinetics in critically ill patients undergoing continuous veno-venous haemodiafiltration |
| Q34112924 | Antibiotic pharmacodynamics in surgical prophylaxis: an association between intraoperative antibiotic concentrations and efficacy |
| Q38420688 | Applications of physiologically based pharmacokinetic modeling for the optimization of anti-infective therapies. |
| Q35637864 | Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MIC |
| Q36162355 | Pharmacokinetic/pharmacodynamic evaluation of anti-infective agents |
| Q44197906 | Pharmacokinetics of ciprofloxacin as a tool to optimise dosage schedules in community patients |
| Q34804885 | The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics |
Search more.